Financial PerformanceISRG reported 1Q25 WW sales of $2.25bn, which was 3% above consensus expectations.
Product StrategyISRG is targeting a broad DV5 launch, with positive feedback on integration and efficiency, providing opportunities for surgeons to improve their learning curve.
Strategic ExpansionIntuitive Ventures' investment in Capstan Medical, which focuses on robotic mitral valve replacement, suggests a strategic interest in advancing cardiac surgery technology.